Login to Your Account


Two Targets to Start

A much-hyped January alliance with the MD Anderson Cancer Center bringing together a suite of technologies in the red hot CAR T-cell space caught the attention of Merck Serono, which inked a potential $941 million deal with Intrexon Corp. more »


Our Habitat for All Things Science
Breaking mirror images for patients' good luck

Given the precision of chemical synthesis processes, small-molecule drugs can be a surprisingly mixed bag of molecules.

If a molecule has a chiral center, synthesis will give a mixture of two molecules that have the identical chemical composition but are mirror images of each other. Technically speaking, they are enantiomers. In the macrobiological world, a person's left and right hand are enantiomers of each other.

READ MORE »

Opinion


Partners in Focus